Health

Alcon was among the participants in a round representing the first funding to be disclosed by the cellular ophthalmology therapeutics developer.

Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.

Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

GV returned for the brain scanning technology provider’s series D round at a $1.2bn valuation, boosting its overall funding to about $250m.

Creo Capital and Legend Capital helped energy storage system developer MS Energy raise an eight-digit sum while Truora and Medfin each received $15m in corporate-backed rounds.

Jodi Olson has reportedly left Alphabet’s early-stage investment arm, where she had been a communications and marketing partner for roughly a decade.

The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.

Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.

The Takeda spinoff is developing a vaccine for acute gastroenteritis caused by norovirus infection, and raised about $140m in August 2021.